Isotretinoin and psychiatric illness in adolescents and young adults

Annals of Pharmacotherapy

Volumn 37, Issue 7-8, 2003, Pages 1124-1127

  Enders, Shelly J ^a   Enders, Jason M ^a,b  

^a ST LOUIS COLLEGE OF PHARMACY   (United States)

^b ST LUKE S HOSPITAL   (United States)

Author keywords

Depression; Isotretinoin; Psychosis; Suicide

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; MINOCYCLINE; RETINOL DERIVATIVE; TETRACYCLINE;

ACNE; ADOLESCENT; CLINICAL TRIAL; DEPRESSION; DRUG MECHANISM; HUMAN; MANIA; MEDLINE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SUICIDAL BEHAVIOR;

EID: 0037765099     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C415     Document Type: Review

References (19)

1. Lamberg L. Acne drug depression warnings highlight need for expert care (letter). JAMA 1998;279:1057.
2. Isotretinoin. In: McEvoy GK, Miller JL, Snoe EK, Welsh OH, Litvak K, Dewey DR, et al., eds. American Hospital Formulary Service. 2002 ed. Bethesda, MD: American Society of Health-System Pharmacists, 2002:3474-81.
3. Wyatt EL, Sutter SH, Drake LA. Dermatological pharmacology. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001:1795-818.
4. Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin (letter). N Engl J Med 2001;344:460.
5. Nightingale SL. From the Food and Drug Administration. JAMA 1998;279:984.
6. Center for Drug Evaluation and Research. Accutane (isotretinoin) FDA labeling supplement approval letter.www.fda.gov/cder/foi/appletter/2002/18662s0461tr.pdf (accessed 2002 Dec 12).
7. Center for Drug Evaluation and Research. Recognizing psychiatric disorders in adolescents and young adults: a guide for prescribers of Accutane (isotretinoin). www.fda.gov/cder/drug/infopage/accutane/accutane_psychdisorders.htm (accessed 2002 Dec 16).
8. USA Today. Accutane acne drug maker sued over suicide. www.usatoday.com/money/health/2002-04-16-accutane-suicide.htm (accessed 2002 Dec 11).
9. Medscape Medical News. Accutane's safety labeling revised for psychiatric disorders, other warnings. www.medscape.com/viewarticle/443909 (accessed 2002 Dec 11).
10. Package insert. Accutane (isotretinoin). www.fda.gov/medwatch/SAFETY/2002/accutane_PI_6-02.pdf (accessed 2002 Dec 11).
11. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17:25-32.
12. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999;140:273-82.
13. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000;136:1231-6.
14. Wysowski DK, Beitz J. Methodological limitations in the study "Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide" editorial. Arch Dermatol 2001;137:1102-3.
15. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 2001;35:S168-75.
16. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45:515-9.
17. Kaplan DW, Love KA. Adolescence. In: Hay WW, Hayward AR, Levin MJ, Sondheimer JM, eds. Current pediatric diagnosis and treatment. 15th ed. New York: McGraw-Hill, 2001:90-114.
18. Aktan S, Ozman E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 2000;39:354-7.
19. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1988;139:846-50.